Top Abstract Purchase Related
Home
>
Node
>
Subnode

Long-term tetrahydroaminoacridine treatment and quantitative EEG in Alzheimer's disease

Kogan, E.A.; Verchovsky, R.G.; Neufeld, M.Y.; Klimovitsky, S.Sh.; Treves, T.A.; Korczyn, A.D.

Journal of Neural Transmission. Supplementum 2007(72): 203-206

2007

ISSN/ISBN: 0303-6995
PMID: 17982896
Document Number: 609023
The development of therapies for Alzheimer's disease (AD) has focused on drugs designed to correct the loss of cholinergic function within the central nervous system. Quantitative EEG (qEEG) changes associated with AD consist of background slowing. One way to study the effects of cholinergic drugs may be through assessment of their qEEG effects. The aim of the current work was to evaluate the effect of long-term treatment with tetrahydroaminoacridine (THA) on qEEG in AD patients.

Document emailed within 1 workday
Secure & encrypted payments

Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Bloom, G.D.; Carlsöö, B.; Danielsson, A.; Gustafsson, H.; Henriksson, R. 1979: Quantitative structural analysis and the secretory behaviour of the rat parotid gland after long and short term isoprenaline treatment Medical Biology 57(4): 224-233
Apperloo, A.J.; de Zeeuw, D.; de Jong, P.E. 1994: Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease Kidney International. Suppl 45: S174-S178
Khaĭrutdinov, E.R.; Shugushev, Z.K.; Maksimkin, D.A.; Faĭbushevich, A.G.; Veretnik, G.I.; Arablinskiĭ, A.V.; Tarichko, I.V. 2012: Endovascular treatment of ischemic heart disease in patients with multivessel coronary artery disease: immediate and long-term results Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 7: 8-14
Boratyńska, M.; Boratyński, J.; Magott, M.; Szewczyk, Z. 1996: The effect of long term erythropoietin treatment on levels of free amino acids in patients with long term hemodialysis Przeglad Lekarski 53(5): 398-401
Alonso López, F.A.; Anzola Fernández, B.; Arratibel Arrondo, J.; Gancedo González, Z. 1993: Who prescribes? Origin and adequacy of long term prescriptions included in a computerized long term treatment programme at a health center Atencion Primaria 12(8): 465-468
Takenaga, S.; Kawahigashi, Y.; Sonoda, Y.; Horikiri, T.; Hirata, K.; Arimura, K.; Osame, M. 1995: Treatment of spastic paraparesis with botulinum toxin with reference to beneficial effects, disease severity and long-term treatment Rinsho Shinkeigaku 35(3): 251-255
Gulyás, A.; Szám, I. 1976: Pyridinolcarbamate in the long-term treatment of ischaemic heart disease Therapia Hungarica 24(2): 63-66
Kåresen, R.; Serch-Hanssen, A.; Thoresen, B.O.; Hertzberg, J. 1981: Crohn's disease: long-term results of surgical treatment Scandinavian Journal of Gastroenterology 16(1): 57-64
Korelitz, B.I.; Adler, D.J.; Mendelsohn, R.A.; Sacknoff, A.L. 1993: Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease American Journal of Gastroenterology 88(8): 1198-1205
Bricaire, H.; Luton, J.P. 1976: 12 years of medical treatment of Cushing's disease. Long-term use of Op, DDD in 46 cases La Nouvelle Presse Medicale 5(6): 325-329
Urbaszek, W.; Modersohn, D.; Schauer, J.; Günther, K. 1976: Current problems in the conservative long-term treatment of ischemic heart disease Zeitschrift für Arztliche Fortbildung 70(1): 2-13
Gugler, R.; Jensen, J.C.; Schulte, H.; Vogel, R. 1989: The course of Crohn disease and side effect profile with long-term treatment using metronidazole Zeitschrift für Gastroenterologie 27(11): 676-682
Markiewicz, M.; Koziara, Z.; Florkiewicz, H.; Miturzyńska-Stryjecka, H. 1981: Prospective studies on the effectiveness of long-term anticoagulant treatment in coronary disease Polski Tygodnik Lekarski 36(10): 369-371
Forni, E.; Orlandoni, G.; Voltolini, P.; Zadra, F.; Stradiotti, G.; Bordoni, P.; Spelzini, P. 1984: Long-term results of the surgical treatment of ileo-colonic Crohn disease Chirurgia Italiana 36(5): 819-826
Sauer, B.; Dietl, H.W.; Kretschmann, H.J.; Mehraein, P. 1986: A quantitative study of the cerebral cortex in Alzheimer's disease and senile dementia using an automatic image analyzing system Journal für Hirnforschung 27(6): 695-702
Birkmayer, W.; Riederer, P.; Ambrozi, L.; Youdim, M.B. 1977: Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study Lancet 1(8009): 439-443
Chu, J.W.; Matthias, D.F.; Belanoff, J.; Schatzberg, A.; Hoffman, A.R.; Feldman, D. 2001: Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486) Journal of Clinical Endocrinology and Metabolism 86(8): 3568-3573
Degos, L. 1994: Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival Leukemia 8(Suppl 2): S6-S8